Statistics for 4basebio PLC (id:3942 4BB)
Valuation metrics
Market cap
185.38M
Enterprise value
164.52M
Trailing P/E (ttm)
-1,911.29
Forward P/E
3.00
PEG ratio
3.00
Price/Sales (ttm)
311.04
Price/Book (mrq)
Enterprise Value/Revenue
276.04
Enterprise Value/EBITDA
-17.08
Overview
Shares outstanding
15.48M
Float
4.90M
Shares short
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
1.12K
Average volume (90 days)
Price summary
52-Week low
640.00
52-Week high
1.82K
52-Week change
42.62%
Beta
1.13
50-Day moving average
1.28K
200-Day moving average
1.32K
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
December 31, 2023
Profitability
Profit margin
67.19%
Operating margin
-1,767.99%
Operational effectiveness
Return on assets
-54.30%
Return on equity
1.56K%
Income statement
Revenue (ttm)
5.00
Revenue per share (ttm)
5.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
340.00K
EBITDA
-9,633,000.00
Net income to common (ttm)
-9,838,000.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
2.72M
Total cash per share (mrq)
3.00
Total debt (mrq)
15.49M
Total Debt/Equity (mrq)
-31.49
Current ratio (mrq)
272.70%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-8,332,000.00
Levered free cash flow (LFCF)
-7,063,500.00